Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

Cite this paper

@article{Choi2009CombinedIO, title={Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors}, author={Yun Jung Choi and Jin Kyung Rho and Byung-suk Jeon and Su Jin Choi and Su Cheol Park and Seung S. Lee and Hye-Ryoun Kim and Cheol Hyeon Kim and Jae Cheol Lee}, journal={Cancer Chemotherapy and Pharmacology}, year={2009}, volume={66}, pages={381-388} }